Design, production and immunomodulatory potency of a novel allergen bioparticle

Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained efficacy. However, it is poorly developed compared to symptomatic drugs. The main reasons come from treatment duration implying monthly injections during 3 to 5 years or daily sublingual use, and the ris...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Gomord, Véronique, Stordeur, Virginie, Fitchette, Anne-Catherine, Fixman, Elizabeth D., Tropper, Guy, Garnier, Lorna, Desgagnes, Réjean, Viel, Sébastien, Couillard, Julie, Beauverger, Guillaume, Trepout, Sylvain, Ward, Brian J., van Ree, Ronald, Faye, Loic, Vézina, Louis-P
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7707610/
https://ncbi.nlm.nih.gov/pubmed/33259521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0242867
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires